ImmuneSensor Therapeutics
ImmuneSensor Therapeutics

ImmuneSensor Therapeutics Information

Contact top employees from ImmuneSensor Therapeutics

Summary

ImmuneSensor is developing novel medicines that target the cGAS (cyclic GMP-AMP synthase) - STING (stimulator of interferon genes) pathway of the innate immune system to treat cancer and autoimmune di...Show more

Organization Website

immunesensor.com

Social Links

linkedIn

Phone Number

+1 469 757 5110

Industries

Headquarters Location

2110 Research Row, Dallas, Texas, 75235 US

Employees Size

1-10 employees

Competitors

Founded
Type
Employees
Revenue
Funding
2018Privately
Held
1 - 25 6M $109.5M
2018Privately
Held
25 - 100 2.5M $113.8M
2018Privately
Held
1 - 25 < 1M $534M
2018Privately
Held
100 - 250 10.5M $1.4B

Employees Turnover 3 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at ImmuneSensor Therapeutics shows a diverse range of experience levels:
38% for 1–2 years13% for 3–4 years25% for 5–7 years13% for 8–10 years13% have over 11 years of service at ImmuneSensor Therapeutics
Ex-employees positions
In Company
In New Company
Contact top employees from ImmuneSensor Therapeutics
Teresa Mooneyham
Vice President, Clinical Operations and Project Management
View
Tom Dubensky
President & CEO
View
Heather Stokes
Vice President Finance
View
Jian Qiu
Chemistry/CMC consultant
View
Qi Wei
Senior Scientist
View
lijun sun
VP, Research and Development
View
You Tong Wu
Associate Director of Biology Department
View

FAQ

ImmuneSensor Therapeutics operates in the Biotech industries. More details can be found on the official website: immunesensor.com.
The headquarters of ImmuneSensor Therapeutics are located in Dallas, United States.
You can contact ImmuneSensor Therapeutics by phone at +1 469 757 5110.
ImmuneSensor Therapeutics currently employs 1-10 people.
Well-known competitors of ImmuneSensor Therapeutics include Aro Biotherapeutics, Cedilla Therapeutics, Day One Biopharmaceuticals and Lyell Immunopharma.
BACK TO TOP